DRKS00020505已完成未知
Increase and decrease of the concentration of choline derivates in the plasma of preterm infants after the administration of unlabeled choline supplements - CHOLINORAL IId
niversitätsklinikum Tübingen0 个研究点目标入组 32 人开始时间: 2020年1月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- one 至 40 Days（—）
- 性别
- All
入选标准
- •1. Gestational age at birth 28-32 weeks
- •2. full enteral feeding
- •3. no acute diseases
排除标准
- •1. Growth retardation / birth weight < 3rd percentile
- •2. genetic diseases
- •3. Diseases, that change the lipid metabolism, especially the gastro intestinum (i.e. stoma, exocrine pancreas insufficience, cholestase), systemic glucocorticoidtherapy, kidney insufficience (creatinine >1.5mg/dl), ventricular funcitonal limitations that influence the liver function
- •4. no informed consent of both parents
研究者
相似试验
已完成
不适用
Increase and decrease of the concentration of choline and choline metabolites in the plasma of male adults after the administration of 4 different unmarked choline supplementsE63.8Other specified nutritional deficienciesDRKS00020454niversitätsklinikum Tübingen6
尚未招募
Unknown
An observational study on correlation between gall bladder stone disease and function of thyroid at Akash hospital, DevanahalliCTRI/2024/02/062329Akash institute of medical sciences and research center
已完成
不适用
A study to evaluate the effect of decreasing cholesterol level by ingestion of botanical ingredient-containing foods.ot applicableJPRN-UMIN000022940Suntory Business Expert Limited200
招募中
4 期
Assessment of the Effects of Cardiopulmonary Phenotype on Oral and intravenous (IV) Frusemide PharmacokineticsPulmonary HypertensionCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemCongestive Heart FailureACTRN12614000461695Flinders University20
已完成
Unknown
The sequential change of serum concentrations of iron metabolic markers after administration of erythropoiesis stimulating agent in HD PatientsHD PatientsJPRN-jRCT1090220198Shigeru Miyazaki28